$100MSeries C, 3 September 2025
Oversubscribed Series C alongside new CEO and chairman Doug Godshall.
- Amount
- $100M
- Stage
- Series C
- Announced
- 3 September 2025
- Lead
- Sofinnova Partners
- Other investors
- Fidelity
- Use of funds
- Oversubscribed Series C alongside new CEO and chairman Doug Godshall.
- Checked
- Announced by the company
- Sources
- Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of biospace.com
Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of news.google.com
Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of pulse2.com